Rode Microphones, LLC et al. v. Zaxcom, Inc.

IPR2025-00230

The PTAB found all challenged claims of Zaxcom’s 8,385,814 patent unpatentable for obviousness over a combination of prior‑art references and granted Zaxcom’s motion to amend with substitute claims.

Jurisdiction
US PTAB
Case Number
IPR2025-00230
Judge(s)
Scott R. Boalick, Kalyan K. Deshpande, Lynne E. Pettigrew
Filing Date
12 April 2024

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Rode Microphones, LLC et al. vs Zaxcom, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-00007

Runergy Alabama Inc et al.vsTrina Solar Co. Ltd.

Runergy has petitioned the PTAB to invalidate all 11 claims of Trina Solar’s 9,722,104 patent, arguing obviousness over multiple prior‑art references. The petition seeks cancellation of the claims and argues discretionary denial does not apply.

patentIPR2025-00423

Berkshire Hathaway Energy Company et al.vsMES, Inc.

Berkshire Hathaway’s MidAmerican Energy and patent owner Birchtech have settled their dispute over a emissions‑control patent, prompting a joint motion to terminate the inter partes review. The Board is asked to dismiss MidAmerican from the proceeding under 35 U.S.C. §317.

patentIPR2025-01084

Orca Security Ltd.vsWiz, Inc.

Orca Security and Wiz have settled their dispute over U.S. Patent 11,929,896 and jointly moved to terminate the inter partes review. The Board is asked to end the proceeding before a final written decision.

patentIPR2026-00154

Target CorporationvsHEADWATER RESEARCH LLC

The PTAB held that all of the challenged claims of Headwater’s ’541 patent are unpatentable, finding anticipation or obviousness over the Rao reference and, for many claims, additional references.

patentIPR2024-00623

Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University

Merck Sharp & Dohme LLC successfully secured institution for its IPR challenge against The Johns Hopkins University regarding oncology/immunotherapy claims. The Board found sufficient evidence to proceed under 35 U.S.C. § 102 and § 103, despite procedural challenges from the Patent Owner.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call